Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerule is a global biotech and nutraceutical company specializing in the development and distribution of wellness products derived from microalgae and other natural sources. The company is best known for its research into 'stem cell enhancers,' specifically leveraging extracts from Aphanizomenon flos-aquae (AFA) to support the natural release of adult stem cells from the bone marrow. Its core product line includes StemEnhance Ultra, Cyactiv, and PlasmaFlo, which are marketed to support stem cell health, reduce systemic inflammation, and improve microcirculation. Cerule operates as a multi-level marketing entity, utilizing a global network of independent distributors to sell its science-backed nutritional supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerule.